LDL-apheresis: Indications and clinical experience in a tertiary cardiac centre

International Journal of Clinical Practice

Volumn 61, Issue 11, 2007, Pages 1834-1842

  Archontakis, S ^a   Pottle, A ^a   Hakim, N ^b   Ilsley, C ^a   Barbir, M ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BEZAFIBRATE; EZETIMIBE; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; APHERESIS; ARTICLE; CARDIOVASCULAR SYSTEM; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL PRACTICE; DISEASE SEVERITY; ENDOCARDITIS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GRAFT RECIPIENT; HEART GRAFT; HETEROZYGOSITY; HIGH RISK PATIENT; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LABORATORY; MALE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAFETY; SEPTICEMIA; TERTIARY HEALTH CARE; TREATMENT INDICATION;

ADULT; AGED; BLOOD COMPONENT REMOVAL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 35348911852     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01488.x     Document Type: Article

References (25)

1. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986 256 : 2823 8.
2. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, Stroke Association. JBS 2: Joint British Societies' Guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005 91 (Suppl. 5 v1 v52.
3. Scandinavian Simvastatin Survival Study. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994 344 : 1383 9.
4. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002 360 : 7 22.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 97.
6. Grundy SM, Cleeman JI, Merz CN et al., National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004 110 : 227 39.
7. Hamilton-Craig I. Statin intolerance: What now? Australian Doctor 2005 Nov. http://www.australiandoctor.com.au/news/a6/0c0376a6.asp (accessed 14 December 2006).
8. Bosch T, Lennertz A, Schenzle D et al., Direct adsorption of lipoproteins (DALI) study group. Direct adsorption of low-density lipoprotein and lipoprotein (a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis. J Clin Apher 2002 17 : 160 9.
9. Kashani A, Phillips CO, Foody JM et al. Risks associated with statin therapy. A systematic overview of randomised clinical trials. Circulation 2006 114 : 2788 97.
10. Bambauer R, Schiel R, Latza R. Low-density lipoprotein apheresis: an overview. Ther Apher Dial 2003 7 : 383 90.
11. Vella A, Pineda AA, O'Brien T. Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia. Mayo Clin Proc 2001 76 : 1039 46.
12. Barbir M, Lazem F, Yacoub M. Lipids in heart transplant patients. In : Betteridge DJ, ed. Lipids and Vascular Disease. Current Issues, 1st edn. London : Martin Dunitz Ltd, 2000 : 151 8.
13. Thompson GR. LDL apheresis. Atherosclerosis 2003 167 : 1 13.
14. Sachais BS, Katz J, Ross J et al. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia. J Clin Apher 2005 20 : 252 5.
15. Poli L, Busnach G. Whole blood selective LDL-apheresis: a comparison of two different absorbers. Int J Artif Organs 2006 29 : 726 32.
16. Mabuchi H, Higashikata T, Kawashiri MA. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia. Transfus Apher Sci 2004 30 : 233 43.
17. Otto C, Kern P, Bambauer R et al. Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia. Artif Organs 2003 27 : 1116 22.
18. Keller C. Indication of low-density lipoprotein apheresis in severe hypercholesterolemia and its atherosclerotic vascular complications: dextran sulfate cellulose low-density lipoprotein apheresis. Ther Apher Dial 2003 7 : 345 9.
19. Bosch T, Wendler T. Efficacy and safety of DALI-LDL-apheresis in two patients treated with the angiotensin II-receptor 1 antagonist losartan. Ther Apher Dial 2004 8 : 269 74.
20. Thompsen J, Thompson PD. A systematic review of LDL apheresis in the treatment of cardiovascular disease. Atherosclerosis 2006 189 : 31 8.
21. Scientific Steering Committee on Behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ 1991 303 : 893 6.
22. Bambauer R. Is lipoprotein (a)-apheresis useful Ther Apher Dial 2005 9 : 142 7.
23. Mabuchi H, Koizumi J, Shimizu M et al., for the Hokuriku-FH-LDL-Apheresis Study Group. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolaemia. Am J Cardiol 1998 82 : 1489 95.
24. Thompson GR, Maher VM, Matthews S. Familial hypercholesterolemia regression study: a randomised trial of low-density lipoprotein apheresis. Lancet 1995 346 : 811 6.
25. Bambauer R, Schiel R, Latza R. Low-density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies. Ther Apher Dial 2000 4 : 213 7.